SlideShare uma empresa Scribd logo
1 de 105
[object Object],[object Object],[object Object]
DEFINITION ,[object Object]
[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
 
[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
INCIDENCE ,[object Object],[object Object]
INCIDENCE ,[object Object],[object Object],[object Object]
Environment Triggers Immunoregulatory Defects and Microbial Exposure Genetic Factor c)Occupation a)Dysfunctional immune host response to normal luminal components a)Westernization b)Sanitation and exposure to infection d)Diet c)Defective barrier function IBD-1 locus and NOD2/CARD15 gene e)Tobacco smoking b)Infection with a specific pathogen Etiology
Westernization ,[object Object],[object Object],[object Object],[object Object]
Sanitation and exposure to infection ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Occupation ,[object Object],[object Object],[object Object],[object Object],[object Object]
Diet ,[object Object],[object Object],[object Object]
Tobacco smoking ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
Genetic Factor  IBD-1 locus and NOD2/CARD15 gene ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
Immunoregulatory Defects and Microbial Exposure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
a) Dysfunctional immune host response to normal luminal components ,[object Object],[object Object],[object Object],[object Object]
b) Infection with a specific pathogen ,[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
c) Defective barrier function ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
Pathologic Findings in IBD
Ulcerative colitis ,[object Object],[object Object],[object Object]
CROHN DISEASE ,[object Object],[object Object],[object Object],[object Object],[object Object]
Morphology. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Endoscopic  image of  colon cancer  identified in the sigmoid colon on screening  colonoscopy  for Crohn's disease.
Crohn's disease can mimic ulcerative colitis on endoscopy. This  endoscopic  image is of Crohn's colitis showing diffuse loss of  mucosal  architecture,  friability  of mucosa in sigmoid colon and exudate on wall, all of which can be found with ulcerative colitis.
Section of  colectomy  showing transmural inflammation
Endoscopy image of  colon  showing  serpiginous  ulcer, a classic finding in Crohn's disease
Ulcerative Collitis ,[object Object]
Endoscopic  image of a  sigmoid colon  afflicted with ulcerative colitis. Note the vascular pattern of the colon granularity and focal friability of the
Colonic  pseudopolyps of a patient with intractable  ulcerative colitis .  Colectomy  specimen
H&E stain of a colonic biopsy showing a crypt abscess, a classic finding in ulcerative colitis
Biopsy sample ( H&E stain ) that demonstrates marked  lymphocytic  infiltration (blue/purple) of the  intestinal mucosa  and architectural distortion of the crypts.
SIGN & SYMPTOM of  IBD
Inflammatory Bowel Disease Symptoms Because inflammatory bowel disease is a  chronic disease  (lasting a long time), you will go through periods in which the disease flares up and causes symptoms. These periods are followed by remission, in which symptoms disappear or decrease and good health returns.  Symptoms may range from mild to severe and generally depend upon the part of the intestinal tract involved. They include the following :
Abdominal cramps and pain  Bloody diarrhea  Severe urgency to have a bowel movement  Fever  Loss of appetite  Weight loss  Anemia (due to blood loss)
Other Symptoms of IBD People with IBD may have symptoms outside the digestive tract, such as: Mouth sores and skin problems Arthritis Eye problems that affect vision
Symptoms  in  Crohn's disease vs. ulcerative colitis Crohn's disease Ulcerative colitis Defecation Often porridge-like sometimes steatorrhea Often mucus-like and with blood Tenesmus Less common More common Fever Common Indicates severe disease Fistulae Common Seldom Weight loss Often More seldom
Findings in diagnostic workup in Crohn's disease vs. ulcerative colitis Sign Crohn's disease Ulcerative colitis Terminal ileum involvement Commonly Seldom Colon involvement Usually Always Rectum involvement Seldom Usually Involvement around the anus Common Seldom Bile duct involvement No increase in rate of primary sclerosing cholangitis Higher rate
Distribution of Disease Patchy areas of inflammation (Skip lesions) Continuous area of inflammation Endoscopy Deep geographic and serpiginous (snake-like) ulcers Continuous ulcer Depth of inflammation May be transmural, deep into tissues Shallow, mucosal Stenosis Common Seldom Granulomas on biopsy May have non-necrotizing non-peri-intestinal crypt granulomas Non-peri-intestinal crypt granulomas not seen Sign Crohn's disease Ulcerative colitis
Pathological features of Crohn’s disease Any portion of small bowel: usually ileum may also involve: any segment of digestive tract Early stages:  involved small bowel has soggy feeling mucosa: reddish purple may show pinpoint erosions known as ‘aphthoid ulcers’ Later stages: prominent ulceration
EARLY STAGE ,[object Object],Fig. 1:  Gross appearance of Crohn's disease. There is a sharp demarcation between the involved and the uninvolved areas.
Fig. 2:  Gross appearance of Crohn's disease. The combination of ulceration and elevated remnants of mucosa results in a typical cobblestone appearance. Fig. 3:  Gross appearance of Crohn's disease. Another example of cobblestone appearance. Fig. 4:  Gross appearance of Crohn's disease. Note the segmental nature of the inflammation, and rigidity of the wall, and flattening of the mucosa are characteristic.
Histopathology Submucosal lymphedema:  early change accompanied by: lymphoid hyperplasia in lamina propria and submucosa scattering of chronic inflammatory cells, including:  plasma cells: including some binucleated forms lymphocytes eosinophils Histiocytes:  some containing prominent lysosomal inclusions mast cells Ulcerations:  begin at top of lymphoid follicles preceded by patchy epithelial necrosis may have vascular pathogenesis
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Crohn's disease ,[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object]
Signs and symptoms Diarrhea-  patients often experience frequent loose or watery  bowel movements. -stool is occasionally accompanied by thick, dark  blood (not bright red smears of blood, which  usually result from a bleeding hemorrhoid) -There is less mucus or pus in the stool than in cases  of ulcerative colitis.
Pain ,[object Object],[object Object],[object Object],[object Object],[object Object]
Fever ,[object Object],[object Object],[object Object],[object Object]
Signs and Symptoms Unrelated To The GI Tract ,[object Object],[object Object],[object Object],[object Object]
Complications  ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object]
Pathological features of Ulcerative colitis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],Fig. 1:  Ulcerative colitis. Acute form with marked hyperemia.
Chronic Stage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Fig. 2:  Ulcerative colitis. Chronic form, showing mucosal ulceration with residual foci of elevated and hyperemic mucosa. Fig. 3:  Pseudopolyps in ulcerative colitis. Fig. 4:  Pseudopolyps in ulcerative colitis.
More Advanced Stage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Fig. 5:  Ulcerative colitis. Late stage, showing total mucosal atrophy.
Quiescent Stage ,[object Object],[object Object],[object Object],[object Object],[object Object]
Histopathology ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Quiescent Stage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Associated Carcinoma ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Fig. 9:  Adenocarcinoma with mucinous features arising in a colon affected by ulcerative colitis. This is a common tumor subtype in this particular setting. Fig. 10:  Dysplasia in ulcerative colitis. Indefinite for dysplasia. Fig. 11:  Dysplasia in ulcerative colitis. Low-grade dysplasia.
Fig. 12:  Dysplasia in ulcerative colitis. High-grade dysplasia. Fig. 13:  Dysplasia in ulcerative colitis. Dysplasia with papillary features.
Signs and Symptoms Diarrhea-  frequent watery stools are the norm -stools are accompanied by thick blood (not  bright red smears of blood, which usually  occur from a bleeding hemorrhoid).  -Mucus or pus also often passes with the stool. -Individual with ulcerative colitis will have stool  of more normal consistency that contains pus  or mucus.
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Signs and Symptoms Unrelated To The GI Tract ,[object Object],[object Object],[object Object],[object Object]
Complications ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
Fig. 6:  Ulcerative colitis. Case complicated with toxic megacolon. Fig. 7:  Ulcerative colitis complicated by toxic megacolon.
INVESTIGATIONS
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Laboratory Tests ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Tests that are not specific for IBD but done to detect and evaluate the inflammation and anemia associated with IBD include: ,[object Object],[object Object],[object Object],[object Object]
Antibody Tests ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Non-Laboratory Tests ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object]
[object Object],[object Object]
Radiology Tests ,[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Medical management of UC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Medical management of UC ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management ,[object Object],[object Object],[object Object]
Management ,[object Object],[object Object],[object Object],[object Object],[object Object]
Drugs for IBD ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Management ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Principles of Surgery ,[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Grading of recommendations ,[object Object],[object Object],[object Object],[object Object]

Mais conteúdo relacionado

Mais procurados

Inflammatory Bowel Disease _RDP
Inflammatory Bowel Disease _RDPInflammatory Bowel Disease _RDP
Inflammatory Bowel Disease _RDPrishi2789
 
Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8Dr. Rubz
 
IBD for 5th 2011.
IBD for 5th 2011.IBD for 5th 2011.
IBD for 5th 2011.Shaikhani.
 
GIT 4th IBD 2015.
GIT 4th IBD 2015.GIT 4th IBD 2015.
GIT 4th IBD 2015.Shaikhani.
 
INFLAMMATORY BOWEL DISEASE
INFLAMMATORY BOWEL DISEASEINFLAMMATORY BOWEL DISEASE
INFLAMMATORY BOWEL DISEASEvelspharmd
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel Disease27168593
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel diseasemed_students0
 
Management of Inflammatory Bowel Disease
Management of Inflammatory Bowel DiseaseManagement of Inflammatory Bowel Disease
Management of Inflammatory Bowel Diseasedrnkhokhar
 
Inflammatory Bowel Disease (IBD) Histopathology
Inflammatory Bowel Disease (IBD) HistopathologyInflammatory Bowel Disease (IBD) Histopathology
Inflammatory Bowel Disease (IBD) HistopathologyFerenc Pinter
 
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...Grupo De Apoyo EII
 
Pathology of Inflammatory bowel disease
Pathology of Inflammatory bowel diseasePathology of Inflammatory bowel disease
Pathology of Inflammatory bowel diseaseShreya D Prabhu
 
Inflammatory bowel disease imaging
Inflammatory bowel disease imagingInflammatory bowel disease imaging
Inflammatory bowel disease imagingKaram Manzalawi
 
inflammatory bowel disease
inflammatory bowel diseaseinflammatory bowel disease
inflammatory bowel diseaserahul arora
 
Inflammatory Bowel Disease (IBD)
Inflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (IBD)
Inflammatory Bowel Disease (IBD)Summit Health
 

Mais procurados (19)

Inflammatory Bowel Disease _RDP
Inflammatory Bowel Disease _RDPInflammatory Bowel Disease _RDP
Inflammatory Bowel Disease _RDP
 
Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8Bohomolets Surgery 4th year Lecture #8
Bohomolets Surgery 4th year Lecture #8
 
IBD for 5th 2011.
IBD for 5th 2011.IBD for 5th 2011.
IBD for 5th 2011.
 
GIT 4th IBD 2015.
GIT 4th IBD 2015.GIT 4th IBD 2015.
GIT 4th IBD 2015.
 
INFLAMMATORY BOWEL DISEASE
INFLAMMATORY BOWEL DISEASEINFLAMMATORY BOWEL DISEASE
INFLAMMATORY BOWEL DISEASE
 
inflammatory bowel disease
inflammatory bowel diseaseinflammatory bowel disease
inflammatory bowel disease
 
Inflammatory Bowel Disease
Inflammatory Bowel DiseaseInflammatory Bowel Disease
Inflammatory Bowel Disease
 
IBD
IBDIBD
IBD
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
Management of Inflammatory Bowel Disease
Management of Inflammatory Bowel DiseaseManagement of Inflammatory Bowel Disease
Management of Inflammatory Bowel Disease
 
Inflammatory Bowel Disease (IBD) Histopathology
Inflammatory Bowel Disease (IBD) HistopathologyInflammatory Bowel Disease (IBD) Histopathology
Inflammatory Bowel Disease (IBD) Histopathology
 
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...
Enfermedad Inflamatoria de Intestino ¿Como Diagnosticarla? - www.grupodeapoyo...
 
Pathology of Inflammatory bowel disease
Pathology of Inflammatory bowel diseasePathology of Inflammatory bowel disease
Pathology of Inflammatory bowel disease
 
Inflammatory bowel disease imaging
Inflammatory bowel disease imagingInflammatory bowel disease imaging
Inflammatory bowel disease imaging
 
IBD
IBDIBD
IBD
 
Inflamatory bowel disease, IBD
Inflamatory bowel disease, IBDInflamatory bowel disease, IBD
Inflamatory bowel disease, IBD
 
Lect 6-inf bowel dis
Lect 6-inf  bowel disLect 6-inf  bowel dis
Lect 6-inf bowel dis
 
inflammatory bowel disease
inflammatory bowel diseaseinflammatory bowel disease
inflammatory bowel disease
 
Inflammatory Bowel Disease (IBD)
Inflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (IBD)
Inflammatory Bowel Disease (IBD)
 

Destaque

Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel diseaseGopi sankar
 
pathology of Parasitic diseases
pathology of Parasitic diseasespathology of Parasitic diseases
pathology of Parasitic diseasesABOHEMEED ALY
 
Clinicopathologic Case Studies
Clinicopathologic Case StudiesClinicopathologic Case Studies
Clinicopathologic Case Studiesnarayannaik
 
L13 inflammatory bowel disease f
L13 inflammatory bowel disease fL13 inflammatory bowel disease f
L13 inflammatory bowel disease fMohammad Manzoor
 
Inflammatory Bowel Disease(IBD).
Inflammatory Bowel Disease(IBD).Inflammatory Bowel Disease(IBD).
Inflammatory Bowel Disease(IBD).Sampath Sai
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel diseaseParichi Buch
 

Destaque (7)

Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
pathology of Parasitic diseases
pathology of Parasitic diseasespathology of Parasitic diseases
pathology of Parasitic diseases
 
Clinicopathologic Case Studies
Clinicopathologic Case StudiesClinicopathologic Case Studies
Clinicopathologic Case Studies
 
Git 6-csbrp
Git 6-csbrpGit 6-csbrp
Git 6-csbrp
 
L13 inflammatory bowel disease f
L13 inflammatory bowel disease fL13 inflammatory bowel disease f
L13 inflammatory bowel disease f
 
Inflammatory Bowel Disease(IBD).
Inflammatory Bowel Disease(IBD).Inflammatory Bowel Disease(IBD).
Inflammatory Bowel Disease(IBD).
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 

Semelhante a Ibd

Inflammatory bowel disease(ibd)”
Inflammatory bowel disease(ibd)”Inflammatory bowel disease(ibd)”
Inflammatory bowel disease(ibd)”samim khan
 
28 - IBD.ppt
28 - IBD.ppt28 - IBD.ppt
28 - IBD.pptAHIKallu
 
Ulcerativecolitis zaidi baqer
Ulcerativecolitis zaidi baqerUlcerativecolitis zaidi baqer
Ulcerativecolitis zaidi baqerBaqer Aliraqi
 
Inflammatory-bowel-disease-pathogenesis.ppt
Inflammatory-bowel-disease-pathogenesis.pptInflammatory-bowel-disease-pathogenesis.ppt
Inflammatory-bowel-disease-pathogenesis.pptMohammadFaisal565026
 
INFLAMMATORY BOWEL DISEASE.pptx
INFLAMMATORY BOWEL DISEASE.pptxINFLAMMATORY BOWEL DISEASE.pptx
INFLAMMATORY BOWEL DISEASE.pptxAnsifK2
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel diseaseTHUSHARA MOHAN
 
Is Clostridium Difficile still a problem in UK hospitals
Is Clostridium Difficile still a problem in UK hospitalsIs Clostridium Difficile still a problem in UK hospitals
Is Clostridium Difficile still a problem in UK hospitalsCarl Aston
 
PScience2014e04 Emily Kollman C2D
PScience2014e04 Emily Kollman C2DPScience2014e04 Emily Kollman C2D
PScience2014e04 Emily Kollman C2DDat Tran, MD
 
Natural products as source of non inflammatory products 2013
Natural products as source of non inflammatory products 2013Natural products as source of non inflammatory products 2013
Natural products as source of non inflammatory products 2013gustavomamor
 
Write a paragraph introducing the immunology pertaining to Crohns D.pdf
Write a paragraph introducing the immunology pertaining to Crohns D.pdfWrite a paragraph introducing the immunology pertaining to Crohns D.pdf
Write a paragraph introducing the immunology pertaining to Crohns D.pdfinfo824691
 
INFLAMMATORY BOWEL DISEASES
INFLAMMATORY BOWEL DISEASESINFLAMMATORY BOWEL DISEASES
INFLAMMATORY BOWEL DISEASESPriyansha Singh
 
First inflammatory bowel disease presentation finished version (2)
First inflammatory bowel disease presentation finished version (2)First inflammatory bowel disease presentation finished version (2)
First inflammatory bowel disease presentation finished version (2)Adina Georgiana
 
Tuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'atTuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'atHarrisonMbohe
 

Semelhante a Ibd (20)

Inflammatory bowel disease(ibd)”
Inflammatory bowel disease(ibd)”Inflammatory bowel disease(ibd)”
Inflammatory bowel disease(ibd)”
 
28 - IBD.ppt
28 - IBD.ppt28 - IBD.ppt
28 - IBD.ppt
 
Diabetes and TB The deadly Combo.pptx
Diabetes and TB The deadly Combo.pptxDiabetes and TB The deadly Combo.pptx
Diabetes and TB The deadly Combo.pptx
 
Ulcerativecolitis zaidi baqer
Ulcerativecolitis zaidi baqerUlcerativecolitis zaidi baqer
Ulcerativecolitis zaidi baqer
 
Inflammatory-bowel-disease-pathogenesis.ppt
Inflammatory-bowel-disease-pathogenesis.pptInflammatory-bowel-disease-pathogenesis.ppt
Inflammatory-bowel-disease-pathogenesis.ppt
 
Crohn Disease
Crohn DiseaseCrohn Disease
Crohn Disease
 
INFLAMMATORY BOWEL DISEASE.pptx
INFLAMMATORY BOWEL DISEASE.pptxINFLAMMATORY BOWEL DISEASE.pptx
INFLAMMATORY BOWEL DISEASE.pptx
 
Dysbiosis & disease chorn
Dysbiosis & disease chornDysbiosis & disease chorn
Dysbiosis & disease chorn
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
Inflammatory bowel disease
Inflammatory bowel diseaseInflammatory bowel disease
Inflammatory bowel disease
 
Is Clostridium Difficile still a problem in UK hospitals
Is Clostridium Difficile still a problem in UK hospitalsIs Clostridium Difficile still a problem in UK hospitals
Is Clostridium Difficile still a problem in UK hospitals
 
Inflammatory Bowel Diseases
Inflammatory Bowel DiseasesInflammatory Bowel Diseases
Inflammatory Bowel Diseases
 
PScience2014e04 Emily Kollman C2D
PScience2014e04 Emily Kollman C2DPScience2014e04 Emily Kollman C2D
PScience2014e04 Emily Kollman C2D
 
Natural products as source of non inflammatory products 2013
Natural products as source of non inflammatory products 2013Natural products as source of non inflammatory products 2013
Natural products as source of non inflammatory products 2013
 
Write a paragraph introducing the immunology pertaining to Crohns D.pdf
Write a paragraph introducing the immunology pertaining to Crohns D.pdfWrite a paragraph introducing the immunology pertaining to Crohns D.pdf
Write a paragraph introducing the immunology pertaining to Crohns D.pdf
 
INFLAMMATORY BOWEL DISEASES
INFLAMMATORY BOWEL DISEASESINFLAMMATORY BOWEL DISEASES
INFLAMMATORY BOWEL DISEASES
 
First inflammatory bowel disease presentation finished version (2)
First inflammatory bowel disease presentation finished version (2)First inflammatory bowel disease presentation finished version (2)
First inflammatory bowel disease presentation finished version (2)
 
Tuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'atTuberculosis by Faith Chelang'at
Tuberculosis by Faith Chelang'at
 
28 - IBD-1.ppt
28 - IBD-1.ppt28 - IBD-1.ppt
28 - IBD-1.ppt
 
Vitamin D and Immunity: COVID-19 Perspectives by Dr Shahjada Selim
Vitamin D and Immunity: COVID-19 Perspectives by Dr Shahjada SelimVitamin D and Immunity: COVID-19 Perspectives by Dr Shahjada Selim
Vitamin D and Immunity: COVID-19 Perspectives by Dr Shahjada Selim
 

Ibd

  • 1.
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.  
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. Environment Triggers Immunoregulatory Defects and Microbial Exposure Genetic Factor c)Occupation a)Dysfunctional immune host response to normal luminal components a)Westernization b)Sanitation and exposure to infection d)Diet c)Defective barrier function IBD-1 locus and NOD2/CARD15 gene e)Tobacco smoking b)Infection with a specific pathogen Etiology
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 29.
  • 30.
  • 31.
  • 32. Endoscopic image of colon cancer identified in the sigmoid colon on screening colonoscopy for Crohn's disease.
  • 33. Crohn's disease can mimic ulcerative colitis on endoscopy. This endoscopic image is of Crohn's colitis showing diffuse loss of mucosal architecture, friability of mucosa in sigmoid colon and exudate on wall, all of which can be found with ulcerative colitis.
  • 34. Section of colectomy showing transmural inflammation
  • 35. Endoscopy image of colon showing serpiginous ulcer, a classic finding in Crohn's disease
  • 36.
  • 37. Endoscopic image of a sigmoid colon afflicted with ulcerative colitis. Note the vascular pattern of the colon granularity and focal friability of the
  • 38. Colonic pseudopolyps of a patient with intractable ulcerative colitis . Colectomy specimen
  • 39. H&E stain of a colonic biopsy showing a crypt abscess, a classic finding in ulcerative colitis
  • 40. Biopsy sample ( H&E stain ) that demonstrates marked lymphocytic infiltration (blue/purple) of the intestinal mucosa and architectural distortion of the crypts.
  • 41. SIGN & SYMPTOM of IBD
  • 42. Inflammatory Bowel Disease Symptoms Because inflammatory bowel disease is a chronic disease (lasting a long time), you will go through periods in which the disease flares up and causes symptoms. These periods are followed by remission, in which symptoms disappear or decrease and good health returns. Symptoms may range from mild to severe and generally depend upon the part of the intestinal tract involved. They include the following :
  • 43. Abdominal cramps and pain Bloody diarrhea Severe urgency to have a bowel movement Fever Loss of appetite Weight loss Anemia (due to blood loss)
  • 44. Other Symptoms of IBD People with IBD may have symptoms outside the digestive tract, such as: Mouth sores and skin problems Arthritis Eye problems that affect vision
  • 45. Symptoms in Crohn's disease vs. ulcerative colitis Crohn's disease Ulcerative colitis Defecation Often porridge-like sometimes steatorrhea Often mucus-like and with blood Tenesmus Less common More common Fever Common Indicates severe disease Fistulae Common Seldom Weight loss Often More seldom
  • 46. Findings in diagnostic workup in Crohn's disease vs. ulcerative colitis Sign Crohn's disease Ulcerative colitis Terminal ileum involvement Commonly Seldom Colon involvement Usually Always Rectum involvement Seldom Usually Involvement around the anus Common Seldom Bile duct involvement No increase in rate of primary sclerosing cholangitis Higher rate
  • 47. Distribution of Disease Patchy areas of inflammation (Skip lesions) Continuous area of inflammation Endoscopy Deep geographic and serpiginous (snake-like) ulcers Continuous ulcer Depth of inflammation May be transmural, deep into tissues Shallow, mucosal Stenosis Common Seldom Granulomas on biopsy May have non-necrotizing non-peri-intestinal crypt granulomas Non-peri-intestinal crypt granulomas not seen Sign Crohn's disease Ulcerative colitis
  • 48. Pathological features of Crohn’s disease Any portion of small bowel: usually ileum may also involve: any segment of digestive tract Early stages: involved small bowel has soggy feeling mucosa: reddish purple may show pinpoint erosions known as ‘aphthoid ulcers’ Later stages: prominent ulceration
  • 49.
  • 50. Fig. 2:  Gross appearance of Crohn's disease. The combination of ulceration and elevated remnants of mucosa results in a typical cobblestone appearance. Fig. 3:  Gross appearance of Crohn's disease. Another example of cobblestone appearance. Fig. 4:  Gross appearance of Crohn's disease. Note the segmental nature of the inflammation, and rigidity of the wall, and flattening of the mucosa are characteristic.
  • 51. Histopathology Submucosal lymphedema: early change accompanied by: lymphoid hyperplasia in lamina propria and submucosa scattering of chronic inflammatory cells, including: plasma cells: including some binucleated forms lymphocytes eosinophils Histiocytes: some containing prominent lysosomal inclusions mast cells Ulcerations: begin at top of lymphoid follicles preceded by patchy epithelial necrosis may have vascular pathogenesis
  • 52.
  • 53.
  • 54.
  • 55.
  • 56. Signs and symptoms Diarrhea- patients often experience frequent loose or watery bowel movements. -stool is occasionally accompanied by thick, dark blood (not bright red smears of blood, which usually result from a bleeding hemorrhoid) -There is less mucus or pus in the stool than in cases of ulcerative colitis.
  • 57.
  • 58.
  • 59.
  • 60.
  • 61.
  • 62.
  • 63.
  • 64.
  • 65. Fig. 2:  Ulcerative colitis. Chronic form, showing mucosal ulceration with residual foci of elevated and hyperemic mucosa. Fig. 3:  Pseudopolyps in ulcerative colitis. Fig. 4:  Pseudopolyps in ulcerative colitis.
  • 66.
  • 67.
  • 68.
  • 69.
  • 70.
  • 71.
  • 72. Fig. 9:  Adenocarcinoma with mucinous features arising in a colon affected by ulcerative colitis. This is a common tumor subtype in this particular setting. Fig. 10:  Dysplasia in ulcerative colitis. Indefinite for dysplasia. Fig. 11:  Dysplasia in ulcerative colitis. Low-grade dysplasia.
  • 73. Fig. 12:  Dysplasia in ulcerative colitis. High-grade dysplasia. Fig. 13:  Dysplasia in ulcerative colitis. Dysplasia with papillary features.
  • 74. Signs and Symptoms Diarrhea- frequent watery stools are the norm -stools are accompanied by thick blood (not bright red smears of blood, which usually occur from a bleeding hemorrhoid). -Mucus or pus also often passes with the stool. -Individual with ulcerative colitis will have stool of more normal consistency that contains pus or mucus.
  • 75.
  • 76.
  • 77.
  • 78.
  • 79.
  • 80. Fig. 6:  Ulcerative colitis. Case complicated with toxic megacolon. Fig. 7:  Ulcerative colitis complicated by toxic megacolon.
  • 82.
  • 83.
  • 84.
  • 85.
  • 86.
  • 87.
  • 88.
  • 89.
  • 90.
  • 91.
  • 92.
  • 93.
  • 94.
  • 95.
  • 96.
  • 97.
  • 98.
  • 99.
  • 100.
  • 101.
  • 102.
  • 103.
  • 104.
  • 105.

Notas do Editor

  1. The active moiety of these drugs is 5-aminosalicylic acid (5-ASA). 5-ASA is absorbed in the small intestine (and may be nephrotoxic), so the design of the various aminosalicylate preparations is based on the binding of 5-ASA by an azo bond to sulfapyridine (sulfasalazine), 4-aminobenzoyl-â-alanine (balsalazide) or to 5-ASA itself (olsalazine), coating with a pH-sensitive polymer (Asacol) or packaging of 5-ASA in microspheres (Pentasa). The azo bonds are broken down by colonic bacteria to release 5-ASA within the colon. The pH-dependent forms are designed to release 5-ASA in the terminal ileum. Luminal pH profiles in patients with inflammatory bowel disease are abnormal and in some patients capsules of 5-ASA coated with pH-sensitive polymer may pass through into the faeces intact. 5-ASA is released from microspheres throughout the small intestine and colon. The mode of action of 5-ASA in inflammatory bowel disease is unknown, but the aminosalicylates have been shown to be effective in inducing remission in mild to moderately active disease and maintaining remission in all forms of disease. Sulfasalazine is being used less frequently because of its wider side-effect profile from the sulphonamide component
  2. With an ileoanal anastomosis , a pouch of ileum is formed that acts as a reservoir. The pouch is anastomosed to the anus at the dentate line following endoanal excision of the mucosa of the distal rectum and anal canal. Continence is usually achieved. A third of patients, however, will experience ‘pouchitis’ in which there is inflammation of the pouch